# Safety and Immunogenicity of ID vs IM Rabies Vaccine

> **NCT07345208** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **International Centre for Diarrhoeal Disease Research, Bangladesh** · enrollment: 90 (estimated)

## Conditions studied

- Rabies

## Interventions

- **BIOLOGICAL:** Rabies vaccine
- **BIOLOGICAL:** Rabies vaccine

## Key facts

- **NCT ID:** NCT07345208
- **Lead sponsor:** International Centre for Diarrhoeal Disease Research, Bangladesh
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-15
- **Primary completion:** 2027-05-15
- **Final completion:** 2027-07-15
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-01-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07345208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07345208, "Safety and Immunogenicity of ID vs IM Rabies Vaccine". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07345208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*